Patients with neuromuscular weakness have a high risk of developing significant respiratory morbidity throughout life. Respiratory failure is recognized as the main cause of mortality in these conditions. Nevertheless, the prevalence, severity, and progression of respiratory impairment may vary significantly across specific neuromuscular conditions. This is due to the combination of skeletal muscle weakness, disease-specific respiratory muscle involvement, and the variable severity of comorbidities affecting respiratory function such as kyphoscoliosis, axial/truncal weakness, and bulbar involvement.
Chapter 2 - Pulmonary pathophysiology of neuromuscular disease
Trucco F;
2023-01-01
Abstract
Patients with neuromuscular weakness have a high risk of developing significant respiratory morbidity throughout life. Respiratory failure is recognized as the main cause of mortality in these conditions. Nevertheless, the prevalence, severity, and progression of respiratory impairment may vary significantly across specific neuromuscular conditions. This is due to the combination of skeletal muscle weakness, disease-specific respiratory muscle involvement, and the variable severity of comorbidities affecting respiratory function such as kyphoscoliosis, axial/truncal weakness, and bulbar involvement.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
Chapter 02 - ATS book.pdf
accesso chiuso
Descrizione: Chapter 2 - Pulmonary pathophysiology of neuromuscular disease, Editor(s): Oscar Henry Mayer, Pulmonary Assessment and Management of Patients with Pediatric Neuromuscular Disease, Academic Press, 2023, Pages 23-36, ISBN 9780323957472, https://doi.org/10.1016/B978-0-323-95747-2.00009-4. (https://www.sciencedirect.com/science/article/pii/B9780323957472000094)
Tipologia:
Documento in versione editoriale
Dimensione
1.04 MB
Formato
Adobe PDF
|
1.04 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.